Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 127 for “"Surrogate markers"”.

  1. Predicting survival outcomes in Myeloma using surrogate markers

    INTRODUZIONE: L'overall survival (OS) e' una misura che dovrebbe essere considerata negli studi clinici randomizzati di fase III sul Mieloma Multiplo prima che un trattamento entri nella pratica clinica, ma il calcolo dell'OS richiede molto tempo. L'obiettivo principale del nostro progetto era …

    catania Repository record for Predicting survival outcomes in Myeloma using surrogate markers (opens in a new tab)

  2. Surrogate markers for Gammahydroxybutyrate (GHB) exposure in cell lines

    … of GHB beyond 12 hours through finding robust surrogate markers of GHB exposure in cell lines. Two approaches were used: Agilent SurePrint G3 Human 8x60K arrays were used firstly to detect changes in gene expression in human monocytic leukaemia TH-P1 blood cells after 24hours GHB exposure and …

    strathclyde Repository record for Surrogate markers for Gammahydroxybutyrate (GHB) exposure in cell lines (opens in a new tab)

  3. Statistical evaluation of surrogate markers in randomized clinical trials

    … effect on such clinical endpoints. Therefore surrogate markers that can predict the treatment effects on the clinical endpoints would be extremely useful in accelerating the drug development process and depicting the mechanisms of drug action. Although candidate surrogate markers are generally …

    bu Repository record for Statistical evaluation of surrogate markers in randomized clinical trials (opens in a new tab) Embargoed until 2999-01-01

  4. Heterogeneous surrogate markers in clinical trials and real-world settings

    Surrogate markers are often used in clinical trials to replace primary outcomes for earlier, less costly, or less burdensome evaluations of treatment effectiveness. However, traditional methods for validating surrogate markers often assume homogeneity in surrogate strength across all individuals, …

    texas Repository record for Heterogeneous surrogate markers in clinical trials and real-world settings (opens in a new tab)

  5. Prognostic and surrogate markers for outcome in the treatment of pulmonary tuberculosis

    … and can take over five years to complete. A surrogate marker for poor outcome (failure at end of treatment or recurrence following successful treatment), the established endpoint in such trials, could shorten trial duration and reduce trial size. Culture results after two months of treatment …

    lshtm Repository record for Prognostic and surrogate markers for outcome in the treatment of pulmonary tuberculosis (opens in a new tab) Download PDF for Prognostic and surrogate markers for outcome in the treatment of pulmonary tuberculosis (opens in a new tab)

  6. The investigation of surrogate markers for post-market surveillance in primary total hip arthroplasty

    … those devices that are outliers. Therefore, surrogate markers of subsequent revision rate are sought to ensure failing devices are detected early.</p> <p>The systematic review investigates which available surrogate markers have been validated against the current National Institute for Health …

    oxford Repository record for The investigation of surrogate markers for post-market surveillance in primary total hip arthroplasty (opens in a new tab)

  7. Evaluation of potential surrogate markers to determine TB treatment response among TB patients in Mbeya, Tanzania

    Background Appropriate markers to reflect TB treatment responses are urgently needed mainly for patient care and their application in clinical trials. Additionally, more potent drug combinations in search for treatment shortening regimen are warranted. This work reports results of the TB treatment …

    lmu-germany Repository record for Evaluation of potential surrogate markers to determine TB treatment response among TB patients in Mbeya, Tanzania (opens in a new tab)

  8. Use of surrogate markers for HIV disease monitoring and disease progression in the Australian HIV Observational Database (AHOD)

    … understanding the ongoing utility of well-known surrogate markers of disease progression and exploring potential new ones is increasingly pertinent. Objectives: The aims of this thesis are: 1) investigating the effect of reducing viral-load test frequency among patients with long-term virological …

    unsw Repository record for Use of surrogate markers for HIV disease monitoring and disease progression in the Australian HIV Observational Database (AHOD) (opens in a new tab)

  9. Serial protein misfolding cyclic amplification (sPMCA) to detect surrogate markers for chronic wasting disease in surface water, municipal water and soil

    Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy of deer and elk. Research has indicated that CWD is transmitted horizontally, and that both blood and saliva can transmit disease. Environmental exposure to pens where infected animals have been kept has resulted in disease …

    colostate Repository record for Serial protein misfolding cyclic amplification (sPMCA) to detect surrogate markers for chronic wasting disease in surface water, municipal water and soil (opens in a new tab)

  10. Changes in serum histologic surrogate markers and procollagen III N- terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy

    … to determine the changes in serum histologic surrogate markers and to identify the serum markers predicting treatment response in patients with chronic hepatitis B (CHB) during entecavir treatment. DESIGN AND METHODS: Sixty CHB patients who received entecavir for > 12 months were included. We …

    ajou Repository record for Changes in serum histologic surrogate markers and procollagen III N- terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy (opens in a new tab) Embargoed until 9999-12-31

  11. The association between surrogate marker response measures and the development of opportunistic illnesses in HIV-infected persons enrolled in a large randomized clinical trial.

    Introduction. Surrogate marker responses are imperfect indicators of response to antiretroviral therapy in HIV. It is proposed that the area under the curve of surrogate marker response will be superior to peak response, or to that measured after a period of therapy. Methods. The database from a …

    ottawa-retro Repository record for The association between surrogate marker response measures and the development of opportunistic illnesses in HIV-infected persons enrolled in a large randomized clinical trial. (opens in a new tab)

  12. Appraising Individual Response of VO2peak Following Exercise Training

    … ii) do individual response classification for surrogate markers of CRF agree with response classification for VO2peak? Our results pertaining to question i) indicated that incorporation of supramaximal verification consistently reduced the standard deviation (SD) of individual response, typical …

    queens Repository record for Appraising Individual Response of VO2peak Following Exercise Training (opens in a new tab)

  13. Optimizing Response to Cardiac Resynchronization Therapy for Patients with Heart Failure

    … mechanisms involved in benefit. Finally, surrogate markers of CRT response are compared to patient important outcomes in a systematic review to understand the relationship. The overarching conclusion is that optimizing CRT response requires individualized pre-implant, implant and post …

    calgary Repository record for Optimizing Response to Cardiac Resynchronization Therapy for Patients with Heart Failure (opens in a new tab)

  14. Direct Comparison of Acute Responses to Isotonic Or Isokinetic Eccentric Muscle Action: Implications For Differential Outcomes In Skeletal Muscle Damage

    … elicits a differential response in regards to surrogate markers of skeletal muscle damage. Purpose: To directly compare between isotonic- and isokinetic-type eccentric contractions for differences in markers of muscle damage. Methods: 24 men were placed into a control (C), isotonic (IT) or …

    south-carolina Repository record for Direct Comparison of Acute Responses to Isotonic Or Isokinetic Eccentric Muscle Action: Implications For Differential Outcomes In Skeletal Muscle Damage (opens in a new tab)

  15. Clinical, Biochemical, and Biological Determinants of Measured Plasma Volume and Total Blood Volume in Patients with Acute Heart Failure

    … often leaves clinicians relying on indirect surrogate markers of volume status. This study evaluated the rela-tionship of actual measured plasma and total blood volume with clinical, biochemical, and biological surrogate markers of volume status in patients with AHF. Methods: In a prospective …

    fu-berlin Repository record for Clinical, Biochemical, and Biological Determinants of Measured Plasma Volume and Total Blood Volume in Patients with Acute Heart Failure (opens in a new tab)

  16. Subclinical Cardiovascular Disease in early Rheumatoid Arthritis and established Giant Cell Arteritis: Insights from Cardiovascular Magnetic Resonance Imaging

    … whether therapeutic interventions can modulate surrogate markers of CV outcomes in RA. Using CMR, this thesis demonstrates the presence of CV abnormalities in early RA (ERA) and established GCA. Changes in vascular function, myocardial tissue composition and ventricular geometry/performance are …

    whiterose Download PDF for Subclinical Cardiovascular Disease in early Rheumatoid Arthritis and established Giant Cell Arteritis: Insights from Cardiovascular Magnetic Resonance Imaging (opens in a new tab)

  17. Discovery of host lipid biomarkers for tuberculosis infection in mice

    … strains, the need for novel drugs is urgent. Surrogate markers, which can help to assess efficacy in clinical and pre-clinical trials of such drugs, will tremendously impact the validation of new TB chemotherapeutics.Here we develop an analytical approach based on the analysis of host lipid …

    nus Repository record for Discovery of host lipid biomarkers for tuberculosis infection in mice (opens in a new tab) Download file for Discovery of host lipid biomarkers for tuberculosis infection in mice (opens in a new tab)

Page 1 of 7